BIOMAT Database Logo BIOMAT Database Logo

Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma. 1984

S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008936 Mitolactol Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs. Dibromodulcitol,NSC-104800,NSC 104800,NSC104800
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003606 Dacarbazine An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564) DTIC,5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide,Biocarbazine,DIC,DTIC-Dome,Decarbazine,Deticene,Dimethyl Imidazole Carboxamide,Dimethyl Triazeno Imidazole Carboxamide,ICDT,NSC-45388,Carboxamide, Dimethyl Imidazole,DTIC Dome,DTICDome,Imidazole Carboxamide, Dimethyl,NSC 45388,NSC45388
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients.
December 1988, American journal of clinical oncology,
S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
Phase II trial of mitolactol in patients with metastatic melanoma.
January 1982, Cancer treatment reports,
S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
March 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma.
June 2000, Clinical cancer research : an official journal of the American Association for Cancer Research,
S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatin.
December 1983, Cancer,
S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
Resistant gestational choriocarcinoma: successful treatment with vinblastine, bleomycin, and cisplatin (VBP).
April 1983, Cancer treatment reports,
S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
Phase II study of mitolactol in metastatic malignant melanoma.
January 1985, Cancer treatment reports,
S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma.
January 1992, European journal of cancer (Oxford, England : 1990),
S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
October 2009, American journal of clinical oncology,
S P Richman, and T M Woodcock, and T T Kubota, and M S Blumenreich, and P S Gentile, and J C Allegra
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group.
December 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!